4C Medical Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 17
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $10.1M
Latest Deal Amount
  • Investors
  • 3

4C Medical General Information

Description

Developer of a novel minimally invasive system designed for the treatment of mitral regurgitation. The company's product directly addresses mitral regurgitation without replacing the native mitral valve to preserve the native mitral annulus and left ventricle, enabling doctors to help patients get access to a minimally invasive solution for the treatment of mitral regurgitation.

Contact Information

Website
www.4cmed.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Biotechnology
Primary Office
  • 6655 Wedgwood Road
  • Suite 160
  • Maple Grove, MN 55311
  • United States
+1 (612) 000-0000

4C Medical Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

4C Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 29-Dec-2020 $10.1M 000.00 Completed Clinical Trials - General
4. Debt - PPP 28-Apr-2020 00000 000.00 Completed Startup
3. Early Stage VC (Series B) 02-Oct-2019 00.000 000.00 000.00 Completed Startup
2. Early Stage VC (Series A) 11-Sep-2018 $17M $29.1M 0000 Completed Startup
1. Seed Round 11-May-2018 $12.1M $12.1M 000.00 Completed Startup
To view 4C Medical’s complete valuation and funding history, request access »

4C Medical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 10,913,919 $0.000100 $1.9 $1.9 1x $1.9 33.64%
To view 4C Medical’s complete cap table history, request access »

4C Medical Executive Team (5)

Name Title Board Seat Contact Info
Saravana Kumar Ph.D Interim Chief Executive Officer & President
Jeffrey Chambers MD Founder, Chief Medical Officer & Chairman
Scott Youngstrom Chief Financial Officer
You’re viewing 3 of 5 executive team members. Get the full list »

4C Medical Board Members (5)

Name Representing Role Since
Buzz Benson Self Board Member 000 0000
Jeffrey Chambers MD 4C Medical Founder, Chief Medical Officer & Chairman 000 0000
Jonathan Chen 4C Medical Board Member 000 0000
William Hoffman 4C Medical Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

4C Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

4C Medical Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Yonghua Capital Corporate Venture Capital 000 0000 000000 0
Anges Québec Angel Group Minority 000 0000 000000 0
Grant Park Ventures Venture Capital Minority 000 0000 000000 0
To view 4C Medical’s complete investors history, request access »

Ready to get started?

Request a free trial